Dual Antithrombotic Therapy with Clopidogrel and Novel Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Real-world Study

INTRODUCTION: For patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI), proper antithrombotic therapy is equivocal. Current guidelines recommend triple therapy, which carries a high risk of bleeding. Recent large trials suggest that dual therapy (DT) with novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Kebernik, Julia, Borlich, Martin, Tölg, Ralph, El-Mawardy, Mohamed, Abdel-Wahab, Mohamed, Richardt, Gert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986673/
https://www.ncbi.nlm.nih.gov/pubmed/29633088
http://dx.doi.org/10.1007/s40119-018-0108-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986673/
https://www.ncbi.nlm.nih.gov/pubmed/29633088
http://dx.doi.org/10.1007/s40119-018-0108-z

Ejemplares similares